Draft:Helena Teede
 | Review waiting, please be patient.
This may take 8 weeks or more, since drafts are reviewed in no specific order. There are 2,652 pending submissions waiting for review.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Reviewer tools
|
| Submission declined on 18 August 2025 by Pythoncoder (talk). The content of this submission includes material that does not meet Wikipedia's minimum standard for inline citations. Please cite your sources using footnotes. For instructions on how to do this, please see Referencing for beginners. Thank you. This submission does not appear to be written in the formal tone expected of an encyclopedia article. Entries should be written from a neutral point of view, and should refer to a range of independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
This draft has been resubmitted and is currently awaiting re-review. |  |
Helena Teede AM is an endocrinologist at Monash Health[1] and a clinician-researcher at [[Monash University[2]]], a Professor of Women’s Health, Equity and Impact. Her research interests include women’s health across the lifespan, [[Polycystic ovary syndrome|PCOS][3]], pregnancy, healthy lifestyle, menopause and gender equality and leadership. She was awarded an Order of Australia in 2021 for contributions to women’s health internationally and inspired a generation of younger women in women’s health, academia and endocrinology.
She is the Director of the Monash Centre for Health Research Implementation (MCHRI),[4] a collaborative partnership between Monash Health and Monash University. MCHRI’s vision is Better Care, Better Equity, Better Health.
Education
[edit]Teede graduated with a medical degree with First Class Honours from Monash University[5] in 1997 and trained as an Endocrinologist.
She completed her PhD and an MBA Program in Leadership and Management. Teede is a Fellow of the Australian Academy of Health and Medical Sciences[6] and Honoury Fellow of Royal Australian and New Zealand College of Obstetrics and Gynaecology (RANZCOG)[7].
Impact on Women’s Health
[edit]Professor Helena Teede, is an Australian public health expert and a pioneering figure in women's health. She is internationally recognised for her contributions to research, policy development, and advocacy aimed at improving health outcomes for women. Her work has helped shape national and international approaches to gender equity in healthcare.
Teede is also known for her commitment to mentoring and capacity-building, particularly among early-career researchers. Through her leadership, she has played a key role in fostering the next generation of professionals in women’s health and implementation science. To date, she has been a nominated supervisor for 48 endocrinologists in training, mentored over 100 women in medicine and research, and supervised more than 55 PhD candidates
Teede has worked on multiple international / NHMRC approved clinical guidelines. She led the International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) 2023[8] and in 2018[9]. She is currently the number one expert worldwide in PCOS[10]. PCOS affects 12% of women worldwide. She is currently leading a global initiative to change the name of PCOS. Research led by Teede and published in The Lancet's Eclinical Medicine[11] shows women with PCOS, clinicians and PCOS societies want to rename PCOS to overcome the misleading implication that it is only an ovarian or gynaecological condition and hope that renaming PCOS will improve diagnosis rates.
Teede has senior roles, including on the Council of the Australian Academy of Health and Medical Sciences[12], she is President Elect of the International Society of Endocrinology[13], and Chairs a WHO[14] task force on healthy pregnancy including National Healthy Pregnancy Initiative.
Teede’s has attracted $69M in grants in the past 8 years, led 3 NHMRC[15] National Centres for Research Excellence, a $7M Horizons[16] 2020 EU implementation RCT grant, Global Alliance of Chronic disease, US PCORI and National Institute for Health and Care Research[17] grants, and seven NHMRC[18] partnerships grants (5 as CIA).
She leads the Advancing Women in Health Care Leadership Initiative, (AWHL)[19] an international partnership initiative for gender equity that has 26 partners. Teede established the Monash University Women in Leadership Program[20], an international leadership program for advancing women in healthcare and health and medical research leadership that has been running for over 8 years and supported over 1000 women.
She is the Project Lead of the Women’s Health Research and Translation Impact Network (WHRTN)[21] which has supported over 60 women’s health research projects and supports the careers of women in research.
Teede was the Executive Director of Monash Partners Academic Health Sciences Centre[22]: from 2015 – 2024.
Her Google Scholar H-Index is 104, with >650 publications, >50,000 citations, in NEJM[23], JAMA[24], JAMA Int Med[25], BMJ[26], Annals Int Med, Lancet Diabetes Endocrinol[27], Nature Disease Primers[28], Nature Communications[29], Nature Reviews Endocrinology[30], PloS Med[31], BMC Med[32] & specialty journals.
Career recognition
[edit]- Order of Australia[33] 2021 – AM for contributions to women’s health internationally
- International Research Engagement Award, Engagement Australia[34], 2023
- Honorary Fellowship of Royal College Obstetrics and Gynaecology UK[35] 2023
- International Laureate Award for Outstanding Leadership in Endocrinology 2020 –US Endocrine Society[36]
- Walter Futterweit Award international award for Excellence in Clinical Research in PCOS 2020
- National Australian Medical Association[37] Women in Leadership 2024
- Engagement Australia Award for International reach in research and Translation 2023
- RANZCOG – Honorary Fellowship 2020
- Diabetes Australia[38] annual award for the greatest contribution to diabetes 2018
- Fellow of the Australian Academy of Health and Medical Sciences 2017
References
[edit]- ^ "Monash Health". Monash Health.
- ^ "Monash University". Monash University. Retrieved 17 September 2025.
- ^ "2023 PCOS Guideline Monash University". Retrieved 17 September 2025.
- ^ "Monash Centre for Health Research and Implementation". Monash Centre for Health Research and Implementation. Retrieved 17 September 2025.
- ^ "Monash University". Monash University. Retrieved 17 September 2025.
- ^ "Australian Academy of Health and Medical Sciences". Australian Academy of Health and Medical Sciences. Retrieved 17 September 2025.
- ^ "Royal Australian and New Zealand College of Obstetrics and Gynaecology (RANZCOG)". Royal Australian and New Zealand College of Obstetrics and Gynaecology (RANZCOG). Retrieved 17 September 2025.
- ^ "International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) 2023". International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) 2023. Retrieved 17 September 2025.
- ^ "International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) 2018". International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) 2018. Retrieved 17 September 2025.
- ^ "Expertscape". Expertscape. Retrieved 17 September 2025.
- ^ Teede, Helena (June 2025). "Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey". Lancet's EClinical Medicine. 84103287 103287. doi:10.1016/j.eclinm.2025.103287. PMC 12273733. PMID 40687737.
- ^ "Australian Academy of Health and Medical Sciences". Australian Academy of Health and Medical Sciences. Retrieved 17 September 2025.
- ^ "International Society of Endocrinology". International Society of Endocrinology. Retrieved 17 September 2025.
- ^ "World Health Organisation". World Health Organisation. Retrieved 17 September 2025.
- ^ "National Health and Medical Research Council". National Health and Medical Research Council. Retrieved 17 September 2025.
- ^ "Horizons Europe". Horizons Europe. Retrieved 17 September 2025.
- ^ "National Institute for Health and Care Research". National Institute for Health and Care Research.
- ^ "NHMRC". NHMRC. Retrieved 17 September 2025.
- ^ "Advancing Women in Healthcare Leadership". Advancing Women in Healthcare Leadership. Retrieved 17 September 2025.
- ^ "Women in Leadership". Women in Leadership. Retrieved 17 September 2025.
- ^ "Women's Health Research Translation and impact Network". Women's Health Research Translation and impact Network. Retrieved 17 September 2025.
- ^ "Monash Partners Academic Health Science Centre". Monash Partners Academic Health Science Centre. Retrieved 17 September 2025.
- ^ "New England Journal of Medicine". New England Journal of Medicine. Retrieved 17 September 2025.
- ^ "JAMA Network". JAMA Network. Retrieved 17 September 2025.
- ^ "JAMA Internal Medicine". JAMA Internal Medicine. Retrieved 17 September 2025.
- ^ "The BMJ Group". The BMJ Group. Retrieved 17 September 2025.
- ^ "The Lancet Diabetes and Endocrinology". The Lancet Diabetes and Endocrinology. Retrieved 17 September 2025.
- ^ "Nature Reviews Disease Primers". Nature Reviews Disease Primers. Retrieved 17 September 2025.
- ^ "Nature Communications". Nature Communications. 2 July 2025. Retrieved 17 September 2025.
- ^ "Nature Reviews Endocrinology". Nature Reviews Endocrinology. 14 July 2025. Retrieved 17 September 2025.
- ^ "PLOS Medicine". PLOS Medicine. Retrieved 17 September 2025.
- ^ "BMC Medicine". BMC Medicine. Retrieved 17 September 2025.
- ^ "Office of the Official Secretary to the Governor General". Office of the Official Secretary to the Governor General. Retrieved 17 September 2025.
- ^ "Engagement Australia". Engagement Australia. Retrieved 17 September 2025.
- ^ "Royal College Obstetrics and Gynaecology UK". Royal College Obstetrics and Gynaecology UK. Retrieved 17 September 2025.
- ^ "US Endocrine Society". US Endocrine Society. Retrieved 17 September 2025.
- ^ "Australian Medical Association". Australian Medical Association. Retrieved 17 September 2025.
- ^ "Diabetes Australia". Diabetes Australia. Retrieved 17 September 2025.